Skip to main content

Pediatric Living Donor Liver Transplantation

  • Chapter
  • First Online:
Pediatric Hepatology and Liver Transplantation

Abstract

Living donor liver transplantation (LDLT) was introduced as an alternative procedure to resolve the issue of organ shortage in the setting of deceased donor liver transplantation, and this modality has been expanded from pediatrics to adults. Nowadays, introduction of LDLT in many countries has resulted in low wait-list mortality and good clinical outcomes. There have been technical and immunological refinements in the field of pediatric LDLT, such as resolving graft size mismatching and overcoming blood type mismatches.

According to the evaluation of a living donor candidate, there are some pitfalls related to the specificities of pediatric liver diseases. When LDLT is being considered for pediatric recipients with genetic background, such as Alagille syndrome and inherited metabolic disorders, the genetic predisposition should be ruled out for the donor candidates. The obstacle of blood type mismatches has been overcome since the introduction of rituximab, although ABO-incompatible LDLT for patients aged less than 1.5 years old do not need any preconditioning regimens for B-cell desensitization.

Reduction procedures for adult left lateral segments, including hyper-reduced grafts and monosegmental grafts, have recently been developed to eliminate size mismatch in LDLT for small children. Monosegmental grafts obviously have advantages in that it reduces the graft thickness to avoid the problems related to “large-for-size” grafts. Obtaining sufficient portal venous (PV) front flow is crucial in pediatric LDLT. The collateral vessels, including left gastric vein, splenorenal shunts, and retroperitoneal shunts, must be carefully devascularized, so-called cruise technique. Splenorenal shunt ligation from anterior approach would be effective. If the native PV is sclerotic with insufficient front flow, especially small caliber of the native PV, PV anastomosis by using interpositional vein graft is indicated.

This LDLT chapter is useful in maintaining high-quality surgery in all pediatric patients and in avoiding unrecognized changes in surgical strategy for all involved in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Broelsch CE, Emond JC, Whichington PF, Thistlethwaite JR, Baker AL, Lichter JL. Application of reduced-sized liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 1990;212:368–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Raia S, Navy JR, Miles S. Liver transplantation from live donors. Lancet. 1989;8661:497.

    Article  Google Scholar 

  3. Nagasue N, Kohno H, Matsuo S, et al. Segmental (partial) liver transplantation from a living donor. Transplant Proc. 1992;24:1958–9.

    CAS  PubMed  Google Scholar 

  4. Tanaka K, Uemoto S, Tokunaga Y, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg. 1993;217:82–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Makuuchi M, Kawasaki S, Noguchi T, et al. Donor hepatectomy for living related partial liver transplantation. Surgery. 1993;113:395–402.

    CAS  PubMed  Google Scholar 

  6. Egawa H, Tanabe K, Fukushima N, et al. Current status of organ transplantation in Japan. Am J Transplant. 2012;12:523–30.

    Article  CAS  PubMed  Google Scholar 

  7. Goyet JD, Hausleithner V, Reding R, et al. Impact of innovative techniques on the waiting list and result in pediatric liver transplantation. Transplantation. 1993;56:1130–6.

    Article  Google Scholar 

  8. Kasahara M, Umeshita K, Inomata Y, et al. Long-term outcomes of pediatric living donor liver transplantation in Japan: an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society. Am J Transplant. 2013;13(7):1830–9.

    Article  CAS  PubMed  Google Scholar 

  9. Kiuchi T, Kasahara M, Uryuhara K, et al. Impact of graft-size mismatching on graft prognosis in liver transplantation from living donors. Transplantation. 1999;67:321–7.

    Article  CAS  PubMed  Google Scholar 

  10. Kasahara M, Fukuda A, Yokoyama S, et al. Living donor liver transplantation with hyper-reduced left lateral segments. J Pediatr Surg. 2008;43:1575–8.

    Article  PubMed  Google Scholar 

  11. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation. 2004;77:403–11.

    Article  PubMed  Google Scholar 

  12. Egawa H, Teramukai S, Haga H, et al. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology. 2008;47:143–52.

    Article  PubMed  Google Scholar 

  13. Farmer DG, Venick RS, McDiarmid SV, et al. Predictors of outcomes after pediatric liver transplantation: an analysis of more than 800 cases performed at single institution. J Am Coll Surg. 2007;204:904–16.

    Article  PubMed  Google Scholar 

  14. McDiarmid SV, Anand R, Martz K, et al. A multivariate analysis of pre-, peri-, and post-transplant factors affecting outcome after pediatric liver transplantation. Ann Surg. 2011;254:145–54.

    Article  PubMed  Google Scholar 

  15. Feng S, Si M, Taranto S, et al. Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl. 2006;12:578–84.

    Article  PubMed  Google Scholar 

  16. Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, Langnas AN, et al. A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation. 2006;81:1373–85.

    Article  PubMed  Google Scholar 

  17. Sakamoto S, Nosaka S, Shigeta T, Uchida H, Hamano I, Karaki C, Kanazawa H, et al. Living donor liver transplantation using grafts with hepatic cysts. Liver Transpl. 2012;18:1415–20.

    Article  PubMed  Google Scholar 

  18. Yamamoto K, Takada Y, Fujimoto Y, Haga H, Oike F, Kobayashi N, Tanaka K. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation. 2007;83:257–62.

    Article  PubMed  Google Scholar 

  19. Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, Fujii K, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation. 2004;78:1501–5.

    Article  PubMed  Google Scholar 

  20. Chu CJ, Hung TH, Hwang SJ, Wang YJ, Yang CF, Lin HC, Lee FY, et al. Association of insulin resistance with hepatic steatosis and progression of fibrosis in Chinese patients with chronic hepatitis C. Hepato-Gastroenterology. 2008;55:2157–61.

    PubMed  Google Scholar 

  21. Yoshizumi T, Taketomi A, Soejima Y, Uchiyama H, Ikegami T, Harada N, Kayashima H, et al. Impact of donor age and recipient status on left-lobe graft for living donor adult liver transplantation. Transpl Int. 2008;21:81–8.

    Article  CAS  PubMed  Google Scholar 

  22. Akamatsu N, Kokudo N. Living Liver Donor Selection and Resection at the University of Tokyo Hospital. Transplant Proc. 2016;48:998–1002.

    Article  CAS  PubMed  Google Scholar 

  23. Kasahara M, Kiuchi T, Uryuhara K, Uemoto S, Fujimoto Y, Ogura Y, Oike F, et al. Role of HLA compatibility in pediatric living-related liver transplantation. Transplantation. 2002;74:1175–80.

    Article  PubMed  Google Scholar 

  24. Kamei H, Oike F, Fujimoto Y, Yamamoto H, Tanaka K, Kiuchi T. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching. Liver Transpl. 2006;12:140–5.

    Article  PubMed  Google Scholar 

  25. Kiuchi T, Harada H, Matsukawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, et al. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation. Transpl Int. 1998;11(Suppl 1):S383–4.

    Article  PubMed  Google Scholar 

  26. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet. 1990;336:519–23.

    Article  CAS  PubMed  Google Scholar 

  27. Farges O, Nocci Kalil A, Samuel D, Arulnaden JL, Bismuth A, Castaing D, Bismuth H. Long-term results of ABO-incompatible liver transplantation. Transplant Proc. 1995;27:1701–2.

    CAS  PubMed  Google Scholar 

  28. Egawa H, Oike F, Buhler L, Shapiro AM, Minamiguchi S, Haga H, Uryuhara K, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation. 2004;77:403–11.

    Article  PubMed  Google Scholar 

  29. Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, Kiuchi T, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation. 1998;65:494–9.

    Article  CAS  PubMed  Google Scholar 

  30. Kiuchi T, Inomata Y, Uemoto S, Satomura K, Egawa H, Okajima H, Yamaoka Y, et al. A hepatic graft tuberculosis transmitted from a living-related donor. Transplantation. 1997;63:905–7.

    Article  CAS  PubMed  Google Scholar 

  31. Huaman MA, Deepe GS Jr, Fichtenbaum CJ. Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection. Pathog Immun. 2016;1:291–303.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kowada A. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries. Travel Med Infect Dis. 2016;14:489–98.

    Article  PubMed  Google Scholar 

  33. Kasahara M, Kiuchi T, Inomata Y, Uryuhara K, Sakamoto S, Ito T, Fujimoto Y, et al. Living-related liver transplantation for Alagille syndrome. Transplantation. 2003;75:2147–50.

    Article  PubMed  Google Scholar 

  34. Whitington PF, Alonso EM, Boyle JT, Molleston JP, Rosenthal P, Emond JC, Millis JM. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis. 1998;21(Suppl 1):112–8.

    Article  PubMed  Google Scholar 

  35. Maestri NE, Brusilow SW, Clissold DB, Bassett SS. Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med. 1996;335:855–9.

    Article  CAS  PubMed  Google Scholar 

  36. Nagasaka H, Yorifuji T, Egawa H, Kikuta H, Tanaka K, Kobayashi K. Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency. J Pediatr. 2001;138:432–4.

    Article  CAS  PubMed  Google Scholar 

  37. Morioka D, Takada Y, Kasahara M, Ito T, Uryuhara K, Ogawa K, Egawa H, et al. Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation. 2005;80:623–8.

    Article  PubMed  Google Scholar 

  38. Rahayatri TH, Uchida H, Sasaki K, Shigeta T, Hirata Y, Kanazawa H, Mali V, et al. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors. Pediatr Transplant. 2017;21(1).

    Article  CAS  Google Scholar 

  39. Te HS, Schiano TD, Das S, Kuan SF, DasGupta K, Conjeevaram HS, Baker AL. Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert’s syndrome in liver transplant recipients. Transplantation. 2000;69:1882–6.

    Article  CAS  PubMed  Google Scholar 

  40. Lachaux A, Aboufadel A, Chambon M, Boillot O, Le Gall C, Gille D, Hermier M. Gilbert’s syndrome: a possible cause of hyperbilirubinemia after orthotopic liver transplantation. Transplant Proc. 1996;28:2846.

    CAS  PubMed  Google Scholar 

  41. Desai R, Collett D, Watson CJ, Johnson P, Evans T, Neuberger J. Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry. Br J Surg. 2014;101:768–74.

    Article  CAS  PubMed  Google Scholar 

  42. Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, et al. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation. 2002;74:1657–63.

    Article  PubMed  Google Scholar 

  43. Tanaka K, Uemoto S, Tokunaga Y, Fujita S, Sano K, Nishizawa T, Sawada H, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg. 1993;217:82–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Sakamoto S, Shigeta T, Hamano I, Fukuda A, Kakiuchi T, Matsuno N, Tanaka H, et al. Graft outflow venoplasty on reduced left lateral segments in living donor liver transplantation for small babies. Transplantation. 2011;91:e38–40.

    Article  PubMed  Google Scholar 

  45. Kasahara M, Kaihara S, Oike F, Ito T, Fujimoto Y, Ogura Y, Ogawa K, et al. Living-donor liver transplantation with monosegments. Transplantation. 2003;76:694–6.

    Article  PubMed  Google Scholar 

  46. Diamond IR, Fecteau A, Millis JM, Losanoff JE, Ng V, Anand R, Song C, et al. Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg. 2007;246:301–10.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Srinivasan P, Vilca-Melendez H, Muiesan P, Prachalias A, Heaton ND, Rela M. Liver transplantation with monosegments. Surgery. 1999;126:10–2.

    Article  CAS  PubMed  Google Scholar 

  48. Kasahara M, Fukuda A, Yokoyama S, Sato S, Tanaka H, Kuroda T, Honna T. Living donor liver transplantation with hyperreduced left lateral segments. J Pediatr Surg. 2008;43:1575–8.

    Article  PubMed  Google Scholar 

  49. McDiarmid SV, Anand R, Martz K, Millis MJ, Mazariegos G. A multivariate analysis of pre-, peri-, and post-transplant factors affecting outcome after pediatric liver transplantation. Ann Surg. 2011;254:145–54.

    Article  PubMed  Google Scholar 

  50. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation. 1999;67:321–7.

    Article  CAS  PubMed  Google Scholar 

  51. McDiarmid SV. Management of the pediatric liver transplant patient. Liver Transpl. 2001;7:S77–86.

    Article  CAS  PubMed  Google Scholar 

  52. Enne M, Pacheco-Moreira L, Balbi E, Cerqueira A, Santalucia G, Martinho JM. Liver transplantation with monosegments. Technical aspects and outcome: a meta-analysis. Liver Transpl. 2005;11:564–9.

    Article  PubMed  Google Scholar 

  53. Kanazawa H, Sakamoto S, Fukuda A, Uchida H, Hamano I, Shigeta T, Kobayashi M, et al. Living-donor liver transplantation with hyperreduced left lateral segment grafts: a single-center experience. Transplantation. 2013;95:750–4.

    Article  PubMed  Google Scholar 

  54. Kasahara M, Sakamoto S, Shigeta T, Uchida H, Hamano I, Kanazawa H, Kobayashi M, et al. Reducing the thickness of left lateral segment grafts in neonatal living donor liver transplantation. Liver Transpl. 2013;19:226–8.

    Article  PubMed  Google Scholar 

  55. Sakamoto S, Kanazawa H, Shigeta T, Uchida H, Sasaki K, Hamano I, Fukuda A, et al. Technical considerations of living donor hepatectomy of segment 2 grafts for infants. Surgery. 2014;156:1232–7.

    Article  PubMed  Google Scholar 

  56. Busuttil RW, Goss JA. Split liver transplantation. Ann Surg. 1999;229:313–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Kasahara M, de Ville de Goyet J. Reducing left liver lobe grafts, more or less? Don’t throw out the baby with the bath water. Pediatr Transplant. 2015;19:815–7.

    Article  PubMed  Google Scholar 

  58. Garbanzo JP, Kasahara M, Egawa H, Ikeda T, Doi H, Sakamoto S, Morioka D, Castro E, Takada Y, Tanaka K. Results of living donor liver transplantation in five children with congenital cardiac malformations requiring cardiac surgery. Pediatr Transplant. 2006;10:923–7.

    Article  PubMed  Google Scholar 

  59. Egawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, Fujita S, Kiuchi T, Hayashi M, Yonemura T, Yoshibayashi M, Adachi Y, Shapiro JA, Tanaka K. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation. 1999;67:712–7.

    Article  CAS  PubMed  Google Scholar 

  60. Kasahara M, Kiuchi T, Inomata Y, Uryuhara K, Sakamoto S, Ito T, Fujimoto Y, Ogura Y, Oike F, Tanaka K. Living-related liver transplantation for Alagille syndrome. Transplantation. 2003;75:2147–50.

    Article  PubMed  Google Scholar 

  61. Miyagawa-Hayashino A, Egawa H, Yorifuji T, Hasegawa M, Haga H, Tsuruyama T, Wen MC, Sumazaki R, Manabe T, Uemoto S. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. Liver Transpl. 2009;15:610–8.

    Article  PubMed  Google Scholar 

  62. Kasahara M, Sakamoto S, Horikawa R, Koji U, Mizuta K, Shinkai M, Takahito Y, Taguchi T, Inomata Y, Uemoto S, Tatsuo K, Kato S. Living donor liver transplantation for pediatric patients with metabolic disorders: the Japanese multicenter registry. Pediatr Transplant. 2014;18:6–15.

    Article  PubMed  Google Scholar 

  63. Enosawa S, Horikawa R, Yamamoto A, Sakamoto S, Shigeta T, Nosaka S, Fujimoto J, Nakazawa A, Tanoue A, Nakamura K, Umezawa A, Matsubara Y, Matsui A, Kasahara M. Hepatocyte transplantation using a living donor reduced graft in a baby with ornithine transcarbamylase deficiency: a novel source of hepatocytes. Liver Transpl. 2014;20:391–3.

    Article  PubMed  Google Scholar 

  64. Kasahara M, Sakamoto S, Kanazawa H, Karaki C, Kakiuchi T, Shigeta T, Fukuda A, Kosaki R, Nakazawa A, Ishige M, Nagao M, Shigematsu Y, Yorifuji T, Naiki Y, Horikawa R. Living-donor liver transplantation for propionic acidemia. Pediatr Transplant. 2012;16:230–4.

    Article  CAS  PubMed  Google Scholar 

  65. Kasahara M, Horikawa R, Sakamoto S, Shigeta T, Tanaka H, Fukuda A, Abe K, Yoshii K, Naiki Y, Kosaki R, Nakagawa A. Living donor liver transplantation for glycogen storage disease type Ib. Liver Transpl. 2009;15:1867–71.

    Article  PubMed  Google Scholar 

  66. Sasaki K, Sakamoto S, Uchida H, Shigeta T, Matsunami M, Kanazawa H, Fukuda A, Nakazawa A, Sato M, Ito S, Horikawa R, Yokoi T, Azuma N, Kasahara M. Two-step transplantation for primary hyperoxaluria: a winning strategy to prevent progression of systemic oxalosis in early onset renal insufficiency cases. Pediatr Transplant. 2015;19:E1–6.

    Article  PubMed  Google Scholar 

  67. Ide K, Muguruma T, Shinohara M, Toida C, Enomoto Y, Matsumoto S, Aoki K, Fukuda A, Sakamoto S, Kasahara M. Continuous veno-venous hemodiafiltration and plasma exchange in infantile acute liver failure. Pediatr Crit Care Med. 2015;16:e268–74.

    Article  PubMed  Google Scholar 

  68. Uchida H, Sakamoto S, Fukuda A, Sasaki K, Shigeta T, Nosaka S, Kubota M, Nakazawa A, Nakagawa S, Kasahara M. Sequential analysis of variable markers for predicting outcomes in pediatric patients with acute liver failure. Hepatol Res. 2017;47(12):1241–51.

    Article  PubMed  Google Scholar 

  69. Sakamoto S, Haga H, Egawa H, Kasahara M, Ogawa K, Takada Y, Uemoto S. Living donor liver transplantation for acute liver failure in infants: the impact of unknown etiology. Pediatr Transplant. 2008;12:167–73.

    Article  PubMed  Google Scholar 

  70. Sakamoto S, Kasahara M, Fukuda A, Tanaka H, Kakiuchi T, Karaki C, Kanazawa H, Kamei K, Ito S, Nakazawa A. Pediatric liver-kidney transplantation for hepatorenal fibrocystic disease from a living donor. Pediatr Transplant. 2012;16:99–102.

    Article  PubMed  Google Scholar 

  71. Sakamoto S, Kasahara M, Mizuta K, Kuroda T, Yagi T, Taguchi T, Inomata Y, Umeshita K, Uemoto S. Japanese Liver Transplantation Society. Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan. Liver Transpl. 2014;20:333–46.

    Article  PubMed  Google Scholar 

  72. Uchida H, Fukuda A, Sasaki K, Hirata Y, Shigeta T, Kanazawa H, Nakazawa A, Miyazaki O, Nosaka S, Mali VP, Sakamoto S, Kasahara M. Benefit of early inflow exclusion during living donor liver transplantation for unresectable hepatoblastoma. J Pediatr Surg. 2016;51:1807–11.

    Article  PubMed  Google Scholar 

  73. Kasahara M, Ueda M, Haga H, Hiramatsu H, Kobayashi M, Adachi S, Sakamoto S, Oike F, Egawa H, Takada Y, Tanaka K. Living-donor liver transplantation for hepatoblastoma. Am J Transplant. 2005;5:2229–35.

    Article  PubMed  Google Scholar 

  74. Egawa H, Oike F, Buhler L, Shapiro AM, Minamiguchi S, Haga H, Uryuhara K, Kiuchi T, Kaihara S, Tanaka K. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation. 2004;77:403–11.

    Article  PubMed  Google Scholar 

  75. Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology. 2008;47:143–52.

    Article  PubMed  Google Scholar 

  76. Kanazawa H, Sakamoto S, Fukuda A, Shigeta T, Loh DL, Kakiuchi T, Karaki C, Miyazaki O, Nosaka S, Nakazawa A, Kasahara M. Portal vein reconstruction in pediatric living donor liver transplantation for patients younger than 1 year with biliary atresia. J Pediatr Surg. 2012;47:523–7.

    Article  PubMed  Google Scholar 

  77. Uchida H, Fukuda A, Masatoshi M, Sasaki K, Shigeta T, Kanazawa H, Nakazawa A, Miyazaki O, Nosaka S, Sakamoto S, Kasahara M. A central approach to splenorenal shunt in pediatric living donor liver transplantation. Pediatr Transplant. 2015;19:E142–5.

    Article  PubMed  Google Scholar 

  78. Matsunami M, Ishiguro A, Fukuda A, Sasaki K, Uchida H, Shigeta T, Kanazawa H, Sakamoto S, Ohta M, Nakadate H, Horikawa R, Nakazawa A, Ishige M, Mizuta K, Kasahara M. Successful living domino liver transplantation in a child with protein C deficiency. Pediatr Transplant. 2015;19:E70–4.

    Article  PubMed  Google Scholar 

  79. Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK. Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant. 2004;4:373–7.

    Article  PubMed  Google Scholar 

  80. Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant. 2015;15(Suppl 2):1–28.

    Article  PubMed  Google Scholar 

  81. Kasahara M, Umeshita K, Inomata Y, Uemoto S, Japanese Liver Transplantation Society. Long-term outcomes of pediatric living donor liver transplantation in Japan: an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society. Am J Transplant. 2013;13:1830–9.

    Article  CAS  PubMed  Google Scholar 

  82. Sakamoto S, Kanazawa H, Shigeta T, Uchida H, Sasaki K, Hamano I, Fukuda A, Nosaka S, Egawa H, Kasahara M. Technical considerations of living donor hepatectomy of segment 2 grafts for infants. Surgery. 2014;156:1232–7.

    Article  PubMed  Google Scholar 

  83. Kasahara M, Sakamoto S, Sasaki K, Uchida H, Kitajima T, Shigeta T, Narumoto S, Hirata Y, Fukuda A. Living donor liver transplantation during the first 3 months of life. Liver Transpl. 2017;23:1051–7.

    Article  PubMed  Google Scholar 

  84. Seda-Neto J, Antunes da Fonseca E, Pugliese R, Candido HL, Benavides MR, Carballo Afonso R, Neiva R, Porta G, Miura IK, Teng HW, Iwase FC, Rodrigues ML, Carneiro de Albuquerque LA, Kondo M, Chapchap P. Twenty years of experience in pediatric living donor liver transplantation: focus on hepatic artery reconstruction, complications, and outcomes. Transplantation. 2016;100:1066–72.

    Article  PubMed  Google Scholar 

  85. Gurevich M, Guy-Viterbo V, Janssen M, Stephenne X, Smets F, Sokal E, Lefebvre C, Balligand JL, Pirotte T, Veyckemans F, Clapuyt P, Menten R, Dumitriu D, Danse E, Annet L, Clety SC, Detaille T, Latinne D, Sempoux C, Laterre PF, de Magnée C, Lerut J, Reding R. Living donor liver transplantation in children: surgical and immunological results in 250 recipients at Université Catholique de Louvain. Ann Surg. 2015;262:1141–9.

    Article  PubMed  Google Scholar 

  86. Sakamoto S, Egawa H, Kanazawa H, Shibata T, Miyagawa-Hayashino A, Haga H, Ogura Y, Kasahara M, Tanaka K, Uemoto S. Hepatic venous outflow obstruction in pediatric living donor liver transplantation using left-sided lobe grafts: Kyoto University experience. Liver Transpl. 2010;16:1207–14.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mureo Kasahara .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kasahara, M., Sakamoto, S., Fukuda, A. (2019). Pediatric Living Donor Liver Transplantation. In: D'Antiga, L. (eds) Pediatric Hepatology and Liver Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-96400-3_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-96400-3_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-96399-0

  • Online ISBN: 978-3-319-96400-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics